Complete Filing Data
Galata Acquisition Corp. II reported Stockholders Equity of -$5.02 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Galata Acquisition Corp. II did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 |
|---|---|---|
| Net Income Loss | $43.6K | -$25.1K |
| Operating Income Loss | -$107.6K | |
| General And Administrative Expense | $42.2K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Stockholders Equity | -$5.0M |
| Temporary Equity Carrying Amount Attributable To Parent | $174.3M |
| Temporary Equity Accretion To Redemption Value | |
| Retained Earnings Accumulated Deficit | -$5.0M |
| Repayments Of Related Party Debt | |
| Offering Costs Included In Accrued Offering Costs | |
| Liabilities Current | $84.4K |
| Liabilities And Stockholders Equity | $175.4M |
| Liabilities | $6.1M |
| Deferred Underwriting Fee Payable | |
| Deferred Underwriting Fee | $6.0M |
| Deferred Offering Costs Paid Through Promissory Note Related Party | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $954.6K |
| Assets Current | $1.1M |
| Assets | $175.4M |
| Accrued Offering Expenses Current | $75.0K |
| Accounts Payable And Accrued Liabilities Current | $9.4K |
| Marketable Securities Noncurrent | |
| Assets Held In Trust Noncurrent | $174.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 |
|---|---|---|
| Stockholders Equity | -$4.9M | -$95.00 |
| Temporary Equity Carrying Amount Attributable To Parent | $172.7M | |
| Temporary Equity Accretion To Redemption Value | $11.9M | |
| Retained Earnings Accumulated Deficit | -$4.9M | |
| Repayments Of Related Party Debt | $202.7K | |
| Offering Costs Included In Accrued Offering Costs | $337.1K | |
| Liabilities Current | $88.4K | |
| Liabilities And Stockholders Equity | $173.9M | |
| Liabilities | $6.1M | |
| Deferred Underwriting Fee Payable | $6.0M | |
| Deferred Underwriting Fee | $6.0M | |
| Deferred Offering Costs Paid Through Promissory Note Related Party | $160.5K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $1.1M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.1M | |
| Assets Current | $1.2M | |
| Assets | $173.9M | |
| Accrued Offering Expenses Current | $75.0K | |
| Accounts Payable And Accrued Liabilities Current | $13.4K | |
| Marketable Securities Noncurrent | $172.7M | |
| Assets Held In Trust Noncurrent |
Cash Flow Statement
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 |
|---|---|
| Proceeds From Sale Of Units Net Of Underwriting Discounts Paid | $169.1M |
| Proceeds From Issuance Of Private Placement | $5.3M |
| Payments To Acquire Investments | $172.5M |
| Payments For Repurchase Of Initial Public Offering | $327.1K |
| Net Cash Provided By Used In Operating Activities | -$222.1K |
| Net Cash Provided By Used In Investing Activities | -$172.5M |
| Net Cash Provided By Used In Financing Activities | $173.8M |
| Increase Decrease In Prepaid Insurance Noncurrent | $68.1K |
| Increase Decrease In Prepaid Insurance | $70.3K |
| Increase Decrease In Prepaid Expenses Other | $21.3K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $13.4K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Sale Of Stock Number Of Shares Issued In Transaction | |
| Preferred Stock Shares Authorized | 1.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 |
| Common Stock Shares Issued | 60.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 |
|---|---|
| Sale Of Stock Number Of Shares Issued In Transaction | 5.3M |
| Preferred Stock Shares Authorized | 1.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 |
| Common Stock Shares Issued |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Stock Issued During Period Value Sale Of Private Placement Warrants | |
| Stock Issued During Period Value New Issues | |
| Prepaid Insurance | $70.3K |
| Prepaid Expense Noncurrent | $50.6K |
| Other Prepaid Expense Current | $29.3K |
| Offering Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | |
| Investment Income Interest | |
| Formation Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | |
| Adjustments To Additional Paid In Capital Warrant Issued | |
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | |
| Operating Costs And Expenses | |
| Accretion Of Class A Ordinary Shares To Redemption Value |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 |
|---|---|---|
| Stock Issued During Period Value Sale Of Private Placement Warrants | $5.3M | |
| Stock Issued During Period Value New Issues | $25.0K | |
| Prepaid Insurance | $70.3K | |
| Prepaid Expense Noncurrent | $68.1K | |
| Other Prepaid Expense Current | $21.3K | |
| Offering Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | 10.3K | |
| Investment Income Interest | $151.2K | |
| Formation Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | 14.7K | |
| Adjustments To Additional Paid In Capital Warrant Issued | $1.8M | |
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $123.9K | |
| Operating Costs And Expenses | $107.6K | |
| Accretion Of Class A Ordinary Shares To Redemption Value | 11.9M |
Most recent annual filing with the SEC: March 27, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.